A method for determining aflatoxin N7-guanine adducts in urine was developed. The hydrolysis procedure was based on 8,9-dihydro-8-(N7- guanyl)-9-hydroxy-aflatoxin-B1 (AFB1-N7-Gua), the N7-guanine adduct of aflatoxin-B1 (1162658) (AFB1). The hydrolysis reaction involved the acidic cleavage of the AFB1-N7-Gua bond for the production of fluorescent derivatives. Urine samples were obtained from two male F344-rats which received a 0.8mg/kg AFB1 injection, and purified by passage through a C18 Sep-Pak cartridge followed by a monoclonal antibody immunoaffinity column. The samples were then injected into a high performance liquid chromatography (HPLC) system utilizing a fluorescence detector set at 365 nanometers (nm) for excitation and 428nm for emission to separate and collect the AFBG peak. The eluate was treated with concentrated hydrochloric-acid at 95 degrees- C for 60 minutes. This hydrolyzed the AFB1G to 8,9-dihydro-8,9- dihydroxyaflatoxin-B1 (AFB1diol). The samples were then quantitated by HPLC with fluorescence detection. Calibration plots of urine samples spiked with AFB1diol standards were linear over the range 39 to 5,000 picograms (pg) hydrolyzed AFB1-N7-Gua. The detection limit was 39pg. The precision obtained for four replicate determinations of urine samples spiked with 39 to 5,000pg AFB1diol expressed as the relative coefficient of variation averaged 11.8%. A well resolved fluorescent peak corresponding to AFB1diol was found. Experiments leading to optimization of the procedure including investigating synchronous fluorescence spectrophotometry (SFS) as an alternative technique were described. The HPLC method was found to be more sensitive than SFS. The authors conclude that the new procedure can detect AFB1G at concentrations that are 100 times lower than available with previously used methods.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.